Engineers Gate Manager’s Lifecore Biomedical LFCR Stock Holding History

Engineers Gate Manager’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$54.1K	Sell	10,300 -14,400	-58%	-$72.5K	﹤0.01%	2128
2026 Q1	$91.9K	Buy	+24,700	New	+$171K	﹤0.01%	2032
2024 Q1	–	Sell	-17,127	Closed	-$106K	–	2123
2023 Q4	$106K	Buy	17,127 +2,615	+18%	+$18.2K	﹤0.01%	1767
2023 Q3	$109K	Sell	14,512 -3,394	-19%	-$31K	﹤0.01%	1592
2023 Q2	$173K	Buy	+17,906	New	+$109K	0.01%	1501
2021 Q3	–	Sell	-14,926	Closed	-$168K	–	1815
2021 Q2	$168K	Sell	14,926 -11,989	-45%	-$138K	0.01%	1439
2021 Q1	$285K	Sell	26,915 -5,497	-17%	-$61.8K	0.01%	1354
2020 Q4	$352K	Buy	32,412 +1,397	+5%	+$14.4K	0.02%	1196
2020 Q3	$301K	Sell	31,015 -9,287	-23%	-$88.5K	0.01%	1249
2020 Q2	$321K	Buy	40,302 +23,801	+144%	+$246K	0.02%	1185
2020 Q1	$143K	Buy	+16,501	New	+$172K	0.01%	1347
2019 Q4	–	Sell	-19,856	Closed	-$216K	–	1740
2019 Q3	$216K	Buy	19,856 +2,207	+13%	+$24K	0.01%	1169
2019 Q2	$165K	Buy	+17,649	New	+$178K	0.01%	1010

Other funds holding LFCR

Wynnefield Capital New York $145M AUM 14.57% 1-Year Est. Return

LPAM

Legion Partners Asset Management Los Angeles, California $40.6M AUM 156.55% 1-Year Est. Return

GRIM

Greenhaven Road Investment Management Greenwich, Connecticut $154M AUM 15.9% 1-Year Est. Return

325 Capital New York $419M AUM 75.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QOP

Quinn Opportunity Partners Charlottesville, Virginia $2.16B AUM 28.56% 1-Year Est. Return

Engineers Gate Manager's LFCR Position: Q2 2026 in Review

Engineers Gate Manager reduced its Lifecore Biomedical (LFCR) stake by 58% in Q2 2026, selling an estimated $72.5K and leaving 10,300 shares worth $54.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2128.

Engineers Gate Manager first reported a position in LFCR in Q2 2019 and has held it in 13 quarters since. The position peaked at $352K in Q4 2020. 99 funds tracked by Wall St. Rank hold LFCR as of Q2 2026.

Engineers Gate Manager held 10,300 shares of Lifecore Biomedical worth $54.1K as of Q2 2026.
Engineers Gate Manager sold 14,400 Lifecore Biomedical shares in Q2 2026, an estimated $72.5K.
Lifecore Biomedical made up ﹤0.01% of Engineers Gate Manager's portfolio in Q2 2026, its #2128 holding.
Engineers Gate Manager first reported a position in Lifecore Biomedical in Q2 2019 and has held it in 13 quarters since.
Engineers Gate Manager's Lifecore Biomedical position peaked at $352K in Q4 2020.
99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q2 2026.

Based on Engineers Gate Manager's 13F filing for Q2 2026, filed 14 Aug 2026.